EAACI Congress 2025

Back
13 - 16 June 2025 Glasgow, United Kingdom

Extending Lanadelumab Dosing Intervals to Every 4 Weeks With Sustained Effectiveness for Hereditary Angioedema Attack Prevention: An Analysis From the Final ENABLE Study Data

Friday 13 Jun, 12:00 PM - 12:00 PM Glasgow, United Kingdom